Generic Medicine Info
May be taken with or without food.
History of depression, pre-existing symptoms of Parkinson's disease, other extrapyramidal disorders.
Special Precautions
Hepatic impairment. Elderly. Pregnancy and lactation. Patient Counselling This drug may cause somnolence, if affected, do not drive or operate machinery. Monitoring Parameters Monitor for extrapyramidal, depressive, and fatigue symptoms.
Adverse Reactions
Significant: Depression, increased serum prolactin, menstrual irregularities, extrapyramidal symptoms. Rarely: progressive fatigue, galactorrhoea. Gastrointestinal disorders: Nausea, vomiting, constipation, stomach pain. Investigations: Weight gain. Metabolism and nutrition disorders: Increased appetite. Musculoskeletal and connective tissue disorders: Myalgia. Nervous system disorders: Drowsiness, somnolence. Psychiatric disorders: Insomnia. Respiratory, thoracic and mediastinal disorders: Rhinitis.
Drug Interactions
Increases sedative effect with hypnotics and tranquillisers. Decreased plasma concentration with phenytoin, carbamazepine.
CIMS Class
Antimigraine Preparations
ATC Classification
N07CA03 - flunarizine ; Belongs to the class of antivertigo preparations.
Disclaimer: This information is independently developed by CIMS based on flunarizine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in